Related Experiment Video

Updated: Jun 30, 2026

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy
09:16

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy

Published on: September 11, 2015

Optimal experimental design in an epidermal growth factor receptor signalling and down-regulation model

F P Casey1, D Baird, Q Feng

  • 1F.P. Casey was with the Center for Applied Mathematics, Cornell University, Ithaca, NY 14853, USA. ferg@cam.cornell.edu

IET Systems Biology
|June 27, 2007
PubMed

Insights

We used optimal experimental design to model epidermal growth factor receptor (EGFR) signaling. This approach accurately reproduced experimental data and suggested new experiments to improve understanding of EGFR regulation.

Area of Science:

  • Systems biology
  • Cellular signaling
  • Molecular dynamics

Background:

  • Epidermal growth factor receptor (EGFR) signaling is crucial for cell growth and is often dysregulated in cancer.
  • Receptor trafficking and down-regulation are key processes controlling EGFR signaling duration and intensity.
  • A newly identified protein complex involving Cbl, Cool-1 (beta-Pix), and Cdc42 may disrupt normal EGFR down-regulation.

Purpose of the Study:

  • To develop and validate a differential equation model for EGFR signaling, trafficking, and down-regulation.
  • To incorporate the role of the Cbl-Cool-1-Cdc42 protein complex in EGFR regulation.
  • To apply optimal experimental design principles to guide future research and reduce model uncertainty.

Main Methods:

  • Development of a mathematical model using differential equations to simulate EGFR pathway dynamics.
  • Integration of experimental data to parameterize and validate the model.
  • Application of optimal experimental design techniques to identify critical experiments for parameter estimation.

Main Results:

  • The model accurately reproduces existing experimental observations of EGFR signaling and down-regulation.
  • The model successfully predicts system behavior and quantifies uncertainties in predictions.
  • Optimal experimental design identified specific experiments that can significantly reduce uncertainty in unmeasurable model components.

Conclusions:

  • Mathematical modeling combined with optimal experimental design provides a powerful framework for studying complex cellular signaling pathways like EGFR.
  • The Cbl-Cool-1-Cdc42 complex plays a significant role in modulating EGFR down-regulation.
  • Future experiments guided by optimal design can efficiently enhance our understanding of EGFR pathway regulation and its disruption.

More Related Videos

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Pharmacodynamic Models: Emax Drug–Concentration Effect Model01:18

Pharmacodynamic Models: Emax Drug–Concentration Effect Model

The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...